Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing ...

Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord ...

A major pharmaceutical manufacturing company is considering planting ground in Houston, with a $5.7 billion proposed ...

Global pharmaceutical giant Eli Lilly & Co. is considering a $5.9 billion plant in northeast Houston, a potential economic ...

Lilly—a manufacturer of medicines like Mounjaro, Zepbound and Ebglyss—is considering purchasing 236 acres from Generation ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...

Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.

The new site will primarily focus on manufacturing medications and distributing them to patients. Lilly officials say the facility will allow them to make new medicines "more efficiently" and with ...

Since establishing itself in Limerick just two years ago, Eli Lilly and Company has had a phenomenal impact on the wider ...

Mike Braun and Eli Lilly ... said the Lilly Medicine Foundry, the largest project announced for the LEAP District, will support about 400 jobs when it is completed in 2027. The facility will ...

Eli Lilly and Company wants to be able ... any concerns about not enough water or power for these facilities are unfounded. "Water is coming,” Gentry said. “We have actually planned the construction ...

The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...